Additionally, we demonstrated that SPOCK1/SIX1 activated the PI3K/AKT/mTOR pathway, consequently promoting BC cell proliferation, accelerating cell cycle progression, and triggering the cell EMT program and metastasis, which provides new targets for BC therapies. The gene discussed is SIX1; the disease is breast cancer.